InvestorsHub Logo
Followers 118
Posts 11961
Boards Moderated 0
Alias Born 12/18/2003

Re: ombowstring post# 170406

Tuesday, 06/15/2021 1:41:39 PM

Tuesday, June 15, 2021 1:41:39 PM

Post# of 232168
Really , All of them..

The refusal to use 4 doses,
The DSMC , not " noticing " during interim , asked few times by Dr Lalezatri , that patients need 2 more weeks of treatment , all this is company problem..

And company like Biogen , show NO CLINICAL benefit in treating Alz during this study , met no endpoints , no p-valiue ,
once a month IV infusion , then soon after MRI of the brain since 30% of patients might develop brain edema or/and hemorrhage ,

And drug is approved . Is that because CEO is much better then Dr NP.

Thank you.

all IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News